Printer Friendly

The effects of power toothbrushing on C-reactive protein levels in nursing home residents: A randomized controlled trial.

ABSTRACT

Objectives: The aim of this analysis was to investigate whether twice-daily use of a rotating-oscillating power toothbrush (Oral-B Professional Care 1000[TM]) in nursing home (NH) residents over a 6-week period, compared to usual care, would reduce systemic inflammation as measured by C-reactive protein levels.

Methods: A repeated measures single-blind randomized controlled trial was conducted with residents from 1 nursing home in Winnipeg, Canada, who were randomized to receive either twice-daily toothbrushing with a rotating-oscillating power toothbrush (PB) or usual care (UC) by caregivers. Consent was obtained from residents or their proxies. Participants had some natural teeth; periodontal inflammation; non-aggressive behaviour; no communicable diseases; were non-smokers; and non-comatose. This article reports on a secondary outcome of this trial that measured the systemic inflammation of participants at baseline and 6 weeks, using a high sensitivity C-reactive protein (hsCRP) assay. Changes in hsCRP were not normally distributed, thus data were analysed using non-parametric methods. Within group changes were measured with the Wilcoxon Signed-Rank Test and between group comparisons of ranked differences employed the Kruskal-Waliis Test. Results: Of 54 participants, 3 died before study completion leaving n = 51. No significant differences in CRP values were found between study groups ([X.sup.2(1)] = 0.191, p = 0.662) with a mean rank score of 27.88 for the PB group and 26.02 for the UC group. Conclusions: Twice-daily power toothbrushing of NH residents' teeth did not significantly reduce levels of systemic inflammation as measured by hsCRP.

RESUME

Objectif : La presente analyse a ete effectuee pour determiner si l'utilisation d'une brosse a dents electrique rotative et oscillante (Oral-B Professional Care 1000") par les residants des centres hospitaliers de soins de longue duree (CHSLD) au cours d'une periode de 6 semaines reduirait l'inflammation systemique telle que mesuree par les niveaux de proteines C reactives, par rapport aux soins habituels. Methodes : Un essai a mesures repetees, a simple insu, aleatoires et controlees a ete effectue aupres de 54 residants d'un CHSLD de Winnipeg, Canada, qui ont ete choisis au hasard pour recevoir soit un brossage de dents 2 fois par jour en utilisant une brosse a dents electrique (BE) rotative et oscillante ou des soins habituels (SH) par des soignants. Les residants ou leurs mandataires ont donne leur consentement. Les participants avaient quelques dents naturelles; de l'inflammation parodontale; un comportement non agressif; n'avaient pas de maladies transmissibles; etaient non-fumeurs; et etaient non-comateux. Le present article signale les resultats secondaires de cet essai qui mesure l'inflammation systemique des participants au depart et a 6 semaines, au moyen d'une epreuve biologique de proteine C reactive tres sensible (hsCRP). Les changements dans les hsCRP n'etaient pas normalement distribues, donc les donnees ont ete analysees au moyen de methodes non parametriques. Les changements au sein des groupes ont ete evalues a l'aide du test Wilcoxon pour les observations appariees et les comparaisons des differences de rangs entre les groupes ont ete evaluees a l'aide du test KruskalWallis. Resultats : Parmi les 54 participants, 3 personnes sont decedees avant la fin de l'etude, laissant n = 51. Aucune difference significative dans les valeurs des hsCRP n'a ete trouvee entre les groupes d'etudes ([X.sup.2(1)] = 0,191; p = 0,662), et la note de classement moyenne etait de 27,88 pour le groupe BE et de 26,02 pour le groupe SH. Conclusions : Le brossage de dents 2 fois par jour des residants de CHSLD au moyen d'une brosse a dents electrique n'a pas reduit de facon significative les niveaux d'inflammation systemique tels que mesures par les hsCRP.

Key words: C-reactive protein, nursing homes, power toothbrushing, randomized controlled trial, systemic inflammation CDHA Research Agenda category: risk assessment and management Trial registered at www.clinicaltrials.gov/ (Registration # NCT01639183)

INTRODUCTION

It is well recognized that the number of seniors is increasing worldwide. The World Health Organization predicts that, between 2015 and 2050, the proportion of the world population over 60 years will nearly double, rising from 12% to 22%. (1) Similarly, the proportion of Canadians 65 years and older is projected to rise from 14% to 25% by 2036. (2) In addition to these population projections, nursing home (NH) residents' degree of illness has increased notably in recent years, (3) and researchers have suggested the demand for NH use will increase considerably in future years. (3,4)

In 2012, Matthews and colleagues reported that 66% of Canadian NH residents had periodontal disease. (5) Similar findings were reported by Compton and Kline in a student assessment of the oral status of residents of chronic care facilities in 2015. (6) Although caregiver staff are responsible for daily oral care, several studies (7-9) including a recent systematic review (10), have reported the oral health of NH residents is in many instances deplorable, not only in Canada but worldwide. These studies have demonstrated that NH staff are reluctant to provide this important activity of daily living to their residents, with factors such as lack of provider time; resident resistance; fear of being bitten; and outright aversion to the provision of this care cited as reasons. (7-10)

While maintaining good oral health into older adulthood has many important health and quality of life benefits, growing evidence also suggests a link between oral and certain systemic diseases, such as cardiovascular disease, stroke, respiratory disease, diabetes, obesity, metabolic syndrome, and more recently Alzheimer disease, arthritis, and end-stage renal disease. (11-13) While no causal linkages have been affirmed, of significance is that, in all of these chronic diseases, including periodontal disease, systemic inflammatory biomarkers, such as C-reactive protein (CRP), a non-specific inflammatory biomarker of systemic inflammation, are elevated. (11-18) CRP is produced by macrophages, endothelial cells, and smooth muscle, and is considered to be an important cardiovascular marker of inflammation. A speculated role of CRP may be in foam cell formation during atherogenesis and, as such, it is considered an important cardiovascular risk predictor. (16,17) This literature has been derived almost exclusively from within the general population. (11-17) No studies on NH residents exist other than those that examine associations between oral health and aspiration pneumonia. (18,19) Numerous community-based oral health studies have shown reductions in overall CRP values following a variety of oral interventions. (20-25) Additionally, several researchers have reported improved oral health to be associated strongly with improved cardiac function among community-dwelling people, (22-27) and also with a reduction of aspiration pneumonia in NHs. (18,19) To date, however, there is no evidence of the extent to which reductions in oral inflammation due to improved oral care are associated with reductions in systemic inflammation among NH residents.

The reportedly poor state of oral health among NH residents, the reluctance of NH staff to provide adequate daily oral care, and the increasingly frail state of these residents call for an intervention that would improve this state of affairs. Several educational interventions have been attempted but with insufficient evidence of their effects as reported in a recent systematic review that included 9 randomized controlled trials and over 3000 NH residents. (28) In a study conducted by Wolden et al. (29) NH caregivers preferred delivering oral care using a power toothbrush, to alleviate their fears of being bitten. The current randomized controlled trial tested the use of a rotating-oscillating power toothbrush as the prime intervention with usual care being the comparison group. The purpose of the secondary analysis reported in this article was to test the extent to which twice-daily oral care using a rotating-oscillating power toothbrush versus usual care for 6 weeks reduced CRP levels as a marker of systemic inflammation.

METHODS

Design

This research used a 2-factor repeated measures single-blinded randomized controlled study design and followed an "intention to treat" protocol (ITT). Ethics approval to conduct this trial was obtained from the University of Manitoba Research Ethics Board for Research on Human Subjects (Bannatyne Campus; Reference # H2012:227) and also from the Deer Lodge Centre (DLC) Research Review Committee where the research took place.

Population

DLC is a government-owned NH with a total of 431 beds; 235 of these beds are located in the NH portion of DLC, comprising 6 units housing between 27 and 36 residents each. One of these units (47 beds) contains 36 regular NH beds plus a specialized "lock down" area with 11 beds. The remaining 196 beds at DLC are part of a chronic care long-term stay hospital. The director of the medical laboratory at DLC, which is operated by a separate organization, Diagnostic Services of Manitoba (DSM), provided the principal investigator (PI) with the laboratory services required for gathering the data for this secondary outcome measure.

Participant recruitment was conducted at the resident-level in 2 stages by the PI and aided by DLC nurse managers in charge of a nursing unit. These nurse managers provided the PI with a list of all residents in their respective units who had some natural teeth present and who, in their opinion, did not normally exhibit overly aggressive behaviour. These professionals also provided proxy contacts for residents unable to consent for themselves. From this initial list, the PI approached those residents or their proxies, who met the broad inclusion criteria, to discuss the study and procure consent. Residents were recruited from 7 of the nursing units in DLC sequentially (6 NH units and 1 chronic care unit) to facilitate the training of caregiver staff and to monitor study progress. Baseline data collection was scheduled in the DLC dental clinic on a unit-by-unit basis once recruitment in the unit was complete.

At the second stage of delimitation, all consenting residents who met the broad inclusion criteria (some natural teeth, no communicable diseases, non-smokers, non-ventilated, non-comatose) were examined orally by the study research assistant-a registered dental hygienist--to ensure that each had some degree of inflammation surrounding their natural teeth as measured by the Modified Gingival Index (MGI) (30) and the Papillary Bleeding Index (PBI). (31) No participants were excluded during this latter stage of delimitation.

Demographic data were collected at study commencement for all participants, including classification of their cognitive status according to the Cognitive Performance Scale (CPS) (32) which appears in their medical chart, in addition to all comorbidities recorded in their medical charts.

Randomization

The PI randomly assigned consenting participants using a restricted randomization technique, where group numbers were placed in sequentially numbered sealed envelopes opened only at the commencement of the study by the PI, to either the power toothbrush (PB: n = 29) or usual care (UC: n = 25) group. The principal outcome of the study assessed the effects of power toothbrushing on oral inflammation (reported elsewhere) (33), while a secondary outcome measured the effects of this intervention on CRP levels, reported in this article. Although the primary study began with 57 participants, only 54 participants consented to having their blood drawn and were included in this analysis, which was conducted over a 6-week period for each resident, but lasted 9 months staggered over 7 nursing units at DLC.

Variables

Independent variables included a) twice-daily power toothbrushing (Oral-B Professional Care 1000[TM]) and b) usual care, for a period of 6 weeks. The dependent variable for this secondary objective was systemic inflammation measured for each participant at baseline and again at the end of the 6-week study. Systemic inflammation was identified utilizing a high-sensitivity test (hsCRP) for the detection of C-reactive protein in the circulating blood. This high-sensitivity test detects much smaller levels of C-reactive protein than the standard test for CRP, at values >0.9 mg/L. (14,34,35) Mean CRP values between 2.5 and 5.0 mg/L of blood correspond to the Centers for Disease Control and Prevention's identification of cardiovascular risk. (34)

Clinical procedures

Caregivers in each DLC unit were informed of the study and taught to use the power toothbrush twice daily for individuals assigned to the PB group and instructed to perform usual care twice daily for those participants in the UC group. This usual care consisted primarily of manual toothbrushing but sometimes included only mouth rinsing, based on resident preference. Additionally, some of the residents were capable of performing their own oral care and preferred to do so. In this instance, staff were instructed to remind and observe the residents conducting their oral care.

Laboratory procedures

One vial of blood was drawn by a DLC registered laboratory technologist from each study participant at baseline and at the end of the 6-week study period; the technologist was blinded to the participants' study group. Once blood was drawn, it was centrifuged and aliquoted within an hour by the laboratory technologist and stored in an ice-packed cooler. On the same day of blood withdrawal, the PI transported the blood samples to the Intercity Medical Laboratory for hsCRP analysis. The Intercity Laboratory utilizes the Mayo Clinic technique for hsCRP analysis comprised of a Tina-quant CRP HS assay on a Roche/Hitachi 917 analyzer (Diamond Diagnostics--USA, Holliston, MA). (35) Results were faxed to the PI within 1 week of analysis.

Statistics

Sample size was calculated using an alpha of 0.05 and a power of 0.8 based on the primary study outcome of oral inflammation (reported elsewhere) (33) and not the secondary outcome reported in this article. Based on these calculations, the minimum sample size was set at 28 residents in each of the intervention and usual care groups. A target sample size was set at 60 residents (30 per group) allowing for a 10% death rate during the course of the study. Although 57 participants began the study, only 54 residents consented to having their blood drawn for the secondary outcome (CRP) analysis.

Change values in hsCRP levels deviated significantly from a normal distribution. As there is no non-parametric equivalent to repeated measures testing, data were analysed in 2 steps. Within-person differences in CRP levels were analysed using the Wilcoxon Signed-Rank Test. (36) This test is typically used as an alternative to the paired student t-test for matched pairs or the t-test for dependent samples, when the population cannot be assumed to be normally distributed. (36) The Kruskal-Wallis non-parametric test was then used to determine if the overall amount of change varied significantly between study groups. (37) This rank-based test may be used on independent variables that are either continuous or ordinal. (37) All tests of statistical significance were set at p < 0.05.

RESULTS

A total of 54 individuals or their proxies provided written consent to participate in the systemic outcome phase of this study. These 54 participants were randomly assigned at the beginning of the primary study to 1 of the 2 intervention groups: 29 in the PB group and 25 in the UC group. Two UC participants and one PB participant passed away after baseline data were collected but prior to study closure. None withdrew as a consequence of the study, thus the ITT protocol was not applied to these individuals. Data from the remaining 51 participants (PB = 28; UC = 23) who completed the 6-week period of intervention were analysed.

This study was conducted in a former veteran's facility where several beds are reserved for veterans. Sixty-seven percent (67%) of the study sample was male, with no statistical difference between study groups (p < 0.335) (Table 1). The mean age of study participants was 85.5 years, also with no significant difference between study groups (p < 0.825). The majority of participants had some form of cognitive impairment as measured using the Cognitive Performance Scale (CPS) (32) (Table 1). Twenty-two percent (22%) of all participants were either cognitively intact or borderline cognitively intact (CPS score of 0 to 1); forty-one percent (41%) were mild to moderately impaired (CPS score of 2 to 3); while 37% of participants were moderate-severe to very severely cognitively impaired (CPS score of 4 to 6). No significant differences in CPS levels were found between the study groups [p < 0.599).

All study participants had at least 1 physical chronic disease, and the majority (81%) had 3 or more chronic diseases (Table 1). While there was no significant difference in the number of comorbid participants between study groups (p < 0.795), significantly more individuals had arthritis in the PB group (31%) compared to the UC group (4%) (p < 0.01). Similarly, significantly more individuals in the PB group had diabetes (31%) as compared to participants in the UC group (8%) (p < 0.03). Conversely, a larger proportion of residents in the UC group had cancer (36%) compared to one resident (3%) in the PB group (p < 0.002). No other statistically significant differences in resident characteristics were noted between the study groups.

No significant differences were found between study groups in systemic measures of inflammation using hsCRP [p = 0.463). The median score of hsCRP at baseline for both study groups combined was 4.0 (IQ, 2.7 to 10), and ranged from 3.5 (IQ, 2.08 to 8.5) for PB residents versus 5.2 (IQ 2.70 to 10.4) for UC members (Table 2).

Resident changes in hsCRP during the 6-week study period are shown in Table 3. For both study groups combined, the median change (week 6 minus baseline) in hsCRP was 0.2 (IQR of-2.10 to 4.28), representing a slight but not statistically significant increase in this marker of systemic inflammation. UC group residents experienced an average decrease in hsCRP scores during the study period (median change value of -0.100; IQR of -5.00 to 5.60), while residents in the PB study group experienced a slight increase in hsCRP during this same time (median change value of 0.375; IQR of-1.78 to 2.47).

Comparisons between study groups of the changes in hsCRP are shown in Table 4. As with the descriptive findings, hsCRP values changed non-significantly over time for both study groups individually (PB: p = 0.564; UC: p = 0.839) and combined, [p = 0.719) and the rank order of these differences did not vary significantly by study group ([X.sup.2(1)] = 0.191, p = 0.662) with a mean rank score of 27.88 for the PB group and 26.02 for the UC group.

DISCUSSION

This study was conducted in a large NH in Winnipeg, Canada; residents were randomly allocated to receive twice-daily oral care using a power toothbrush or standard (usual) care for a 6-week period. The purpose of the present analysis was to determine if power toothbrush use (versus usual care) resulted in a statistically significant reduction in levels of C-reactive protein (as a measurement of systemic inflammation) across study groups.

The results of this research failed to reject the null hypothesis of this question that the level of CRP, as a marker of systemic inflammation, would be improved with the intervention of the power toothbrush as compared to usual care. Given the many factors influencing systemic inflammation in NH residents (e.g., numerous chronic diseases, proximity to death) (13,16,34-38,39), it is not surprising that CRP data were highly skewed at both baseline and follow-up. With these caveats, no significant improvement in CRP was found from baseline to week 6 of this study, overall or in either study group. One potential explanation for this result may be the poor levels of caregiver adherence to oral care (reported elsewhere). (39) This explanation, however, is not likely, given the documented improvements in oral health in this study (reported elsewhere). (33) This result is in contrast to numerous studies, albeit not conducted in NHs, which have shown clear associations between improvements in oral health and reductions in CRP. (40-43)

Oral health is only one of many factors thought to influence systemic levels of inflammation. Cardiovascular disease, arthritis, cancer, dementia/Alzheimer disease, and diabetes all are inflammatory in nature and therefore influence systemic CRP levels. (27,38,44-46) Since periodontal disease is only one source of inflammation, and given the high prevalence of comorbid chronic diseases among residents, the lowering of this single source of inflammation is likely insufficient to over-ride the effects of all other contributing factors. In this study population, the majority (81%) had 3 or more comorbidities such as diabetes, arthritis, cardiovascular disease, and dementia, all of which are inflammatory in nature.

One of the limitations of this study was the vast amount of variance in CRP levels at baseline with values ranging from 0.37 mg/L to 84.6 mg/L. No exclusion criteria were applied to CRP values as this was not the primary study question. Categorizing participants according to baseline CRP scores may have resulted in a different outcome. However, it would have also required a much larger sample size to accommodate randomization into 2 groups.

Numerous studies including 3 systematic reviews have confirmed that individuals with periodontitis have higher serum CRP concentrations as compared to those without periodontitis. (14,15,19,21) Similarly, a case-control study by Pejcic et al. (22) reaffirmed these findings, not only reporting significantly higher levels of CRP in those with periodontitis, but also demonstrating a dose-response effect by separating subjects with periodontitis into moderate and severe periodontitis groups.

It would seem logical that removing this source of oral inflammation would help to lower overall levels of systemic inflammation. Interestingly, several studies (23-25) have documented such positive reductions in overall CRP following periodontal interventions including several systematic reviews and meta-analyses (19-21), while other similar studies have not demonstrated the same results (47-49). Reasons for these inconsistencies at this time are unknown, however the possibility of alternate disease pathways may be one explanation. Another possible explanation may be the overall burden of disease as suggested by the current study outcome. However, the results of a recent systematic review by Teeuw21 and colleagues were in direct contrast to the current study findings; Teeuw and colleagues reported significant reductions in CRP levels in only those with other comorbidities. They speculated this result was due to higher levels of baseline CRP for those study participants compared to those without a comorbidity. (21)

Since the majority of these studies employed more invasive interventions such as scaling and root planing, perhaps the daily toothbrushing utilized in this current study was not sufficient enough to have an effect on lowering CRP levels. However, a large epidemiological study conducted in Scotland found reduced levels of CRP in those who brushed regularly compared with nonbrushers. (50) The difference was that the study population in the de Oliveira (50) study was the general public rather than NH residents.

The potential for oral care strategies to reduce CRP levels in the body and to improve endothelial dysfunction and carotid intima media lumen size may have major health benefits for NH residents. CRP has also been identified as an important diagnostic and prognostic tool in NH-associated pneumonia. (51) Arinzon and colleagues found CRP to be positively correlated with the rate of death in those with pneumonia (r = 0.493, p < 0.001) and suggested that CRP values be determined for all NH patients suspected of having pneumonia. (51)

For frail older adults, such as NH residents, who have numerous chronic diseases that elevate their systemic inflammatory levels, more invasive oral interventions may be required to reduce their systemic inflammatory levels. A combination of frequent periodontal debridement treatments along with daily tooth brushing may subsequently reduce systemic inflammation, hence helping to improve their overall health. Further studies, therefore, are required to investigate such combinations of procedures conducted with NH residents to lower their CRP levels.

CONCLUSION

Oral hygiene interventions using either twice-daily brushing with a power toothbrush or standard care both failed to lower CRP values in NH residents over a 6-week period. The authors conclude that daily toothbrushing efforts are not sufficient enough to lower the high levels of CRP in NH residents given the presence of 3 or more chronic comorbidities found in over 80% of study participants. More invasive oral hygiene interventions may be required to have an impact on lowering systemic inflammation in this unique population group.

ACKNOWLEDGEMENTS

This study was funded by the Canadian Foundation for Dental Hygiene Research and Education. Power toothbrushes were provided by the Proctor Et Gamble Company, Cincinnati, OH, USA.

CONFLICT OF INTEREST

The authors have declared no conflicts of interest. REFERENCES

(1.) World Health Organization. Ageing and health [Internet], Fact Sheet No. 404, September 2015. Available from: http://www.who.int/mediacentre/factsheets/fs404/en/

(2.) Statistics Canada. Population projections for Canada, provinces and territories:2009 to 2039. Catalogue no. 91-520-X. Ottawa: Minister of Industry; 2010. Available from: http://www.statcan.qc.ca/pub/91-520-X/91-520-x2010001-ena.pdf

(3.) Doupe M, Fransoo R, Chateau D, Dik N, Burchiil C, Sooden R, et al. Population aging and the continuum of older adult care in Manitoba. Winnipeg, MB: Manitoba Centre for Health Policy; November 2010.

(4.) Menee VH, Manitoba Centre for Health Policy. The health and health care use of Manitoba's seniors: Have they changed over time? Winnipeg, MB: Manitoba Centre for Health Policy; 2002.

(5.) Matthews DC, Clovis JB, Brillant MGS, Filiaggi MJ, McNally ME, et al. Oral health status of long-term care residents: A vulnerable population. J Can Dent Assoc. 2012;78(1):c3.

(6.) Compton SM, Kline LA. Oral health assessment and staff perspectives following a student practicum in long-term care settings. Can J Dent Hyg. 2015;49(1):11-20.

(7.) Chalmers JM, Carter KD, Spencer AJ. Oral health of Adelaide nursing home residents: longitudinal study. Australas J Ageing. 2004;23(2):63-70.

(8.) Coleman P, Watson NM. Oral care provided by certified nursing assistants in nursing homes. J Am GeriatrSoc. 2006;54(1):138-43.

(9.) Dharamsi S, Jivani K, Dean C, Wyatt C. Oral care for frail elders: Knowledge, attitudes, and practices of long-term care staff. J DentEduc. 2009;73(5):581-88.

(10.) Hoben M, Clarke A, Huynh KT, Kobagi N, Kent A, Hu H, et al. Barriers and facilitators in providing oral care to nursing home residents from the perspective of care aides: A systematic review and meta-analysis. IntJNursStud. 2017;73:34-51.

(11.) Linden GJ, Lyons A, Scannapieco FA. Periodontal systemic associations: Review of the evidence. J Periodontal. 2013;84(4 Suppl.):S8-S19 doi:10.1902/jop.2013.1340010.

(12.) Iacopino AM. Maintaining oral health in the aging population: The importance of the periodontal-systemic connection in the elderly. Grand Rounds in Oral-Systemic Medicine. 2006;3:25-37e.

(13.) Hein C, Cobb C, Iacopino A. Report of the independent panel of experts of The Scottsdale Project. Grand Rounds in Oral-Systemic Medicine. 2007;2(Suppl 2.).

(14.) Gomes-Filho IS, Freitas Coelho JM, da Cruz SS, Passos JS, Teixeira de Freitas CO, Aragao Farias NS, et al. Chronic periodontitis and C-reactive protein levels. J Periodontol. 2011;82(7):969-78.

(15.) Chandy S, Joseph K, Sankaranarayan A, Isaac A, Babu G, Wilson B, Joseph J. Evaluation of C-reactive protein and fibrinogen in patients with chronic and aggressive periodontitis: A clinico-biochemical study. J Clin Diagnostic Res. 2017;Mar 11 (03) :ZC41-45.

(16.) Gapski R, Cobb CM. Chronic inflammatory periodontal disease: A risk factor for cardiovascular disease and ischemic stroke? Grand Rounds in Oral-Systemic Medicine. 2006(1):14-22.

(17.) Scannapieco FA, Bush RB, Paju S. Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease. A systematic review. Ann Periodontol. 2003;8(1):54-69.

(18.) Azarpazhooh A, Leake JL. Systematic review of the association between respiratory diseases and oral health. J Periodontol. 2006;77(9):146

(19.) Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol. 2008;35(4):277-90.

(20.) Freitas CO, Gomes-Fiiho IS, Naves RC, Nogueira Filho GR, Cruz SS, Santos CA, et al. Influence of periodontal therapy on C-reactive protein level: A systematic review and meta-analysis. J Appl Oral Sei. 2012;20:1-8.

(21.) Teeuw WJ, Slot DE, Susanto H, Gerdes VEA, Abbas F, D'Aiuto F, Kastelein JJP. Treatment of periodontitis improves the atherosclerotic profile: A systematic review and meta-analysis. J Clin Periodontol. 2014 Jan;41 (1):70-7.

(22.) Pejcic A, Kesic L, Milasin J. C-reactive protein as a systemic marker of inflammation in periodontitis. Eur J Clin Microbiol Infect Dis. 2011;30(3):407-14.

(23.) Shimada Y, Komatsu Y, Ikezawa-Suzuki I, Tai H, Sugita N, Yoshie H. The effect of periodontal treatment on serum leptin, interleukin-6, and C-reactive protein. J Periodontol. 2010;81(8):1118-123.

(24.) Taylor B, Toiler G, Morel-Kopp M, Carey H, Carter T, Elliott M, et al. The effect of initial treatment of periodontitis on systemic markers of inflammation and cardiovascular risk: A randomized controlled trial. EurJ Oral Sei. 2010;118(4):350-56.

(25.) D'Aiuto F, Orlandi M, Gunsolley JC. Evidence that periodontal treatment improves biomarkers and CVD outcomes. J Clin Periodontol. 2013;40:S85-S105.

(26.) Li C, Lv Z, Shi Z, Zhu Y, Wu Y, Li L, Iheozor-Ejiofor Z. Periodontal therapy forthe management of cardiovascular disease in patients with chronic periodontitis. Cochrane Database Syst Rev. 2014; Issue 8. Art. No.: CD009197. doi: 10.1002/14651858.CD009197. pub2..

(27.) Acharya A, Bhavsar N, Jadav B, Parikh H. Cardioprotective effect of periodontal therapy in metabolic syndrome: A pilot study in Indian subjects. Metab Syndr Relat Disord. 2010;8:335-41.

(28.) Albrecht M, Kupfer R, Reissmann DR, Mulhauser I, Kopke S. Oral health educational interventions for nursing home staff and residents. Cochrane Database Syst Rev. 2016 Sept. 30;9;CD010535.

(29.) Wolden H, Strand GV, Gjellestad A. Caregivers' perceptions of electric versus manual toothbrushes for the institutionalised elderly. Gerodontology. 2006;23(2):106-110.

(30.) Lobene RR, Weatherford T, Ross NM, Lamm RA, Menaker L. A modified gingival index for use in clinical trials. Clin Prev Dent. 1986 January-February;8(1):3-6.

(31.) Loesche WJ. Association of the oral flora with important medical diseases. CurrOpin Periodontal. 1997;4:21-28.

(32.) Morris JN, Fries BE, Mehr DR, Hawes C, Phillips C, Mor V, et al. MDS cognitive performance scale. J Gerontol. 1994;49(4):174-82.

(33.) Lavigne SE, Doupe MB, Iacopino AM, Mahmud, S, Elliott L. The effects of power toothbrushing on periodontal inflammation In a Canadian nursing home population: A randomized controlled trial. Int J Dent Hyg. 2016;00:1-7. doi: 10.1111/idh.12268.

(34.) Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, III, Criqui M, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499-511.

(35.) Eda S, Kaufmann J, Roos W, Pohl S. Development of a new microparticle-enhanced turbidietric assay for C-reactive protein with superior features in sensitivity and dynamic range. J Clin Lab Anal. 1998;12(3) :137-44.

(36.) Wikipedia Encyclopedia. Wilcoxon Signed-Rank Test. 2014 [cited 2017 Sept 12], Available from: en.m.wikipedia.ora/wiki/Wilcoxin_signed-rank test

(37.) Minium EW, Clarke RB. Elementsofstatistical reasoning. Toronto: John Wiley ft Sons; 1982.

(38.) Ridker PM, Silvertown JD. Inflammation, C-reactive protein, and atherothrombosis. J Periodontal. 2008;79(8 Suppl.):1544-551.

(39.) Lavigne SE. Effects of power toothbrushing on oral inflammation, caregiver adherence and systemic inflammation in a sample of nursing home residents [PhD Dissertation], Winnipeg, MB: University of Manitoba; 2015. Available from: http://hdl.handle. net/1993/30403

(40.) Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, et al. Treatment of periodontitis and endothelial function. N Engl J Med. 2007;356(9) :911-20.

(41.) D'Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res. 2005;84(3):269-73.

(42.) Seinost G, Wimmer G, Skerget M, Thaller E, Brodmann M, Gasser R, et al. Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am Heart J. 2005; 149(6) :1050-1054.

(43.) Piconi S, Trabattoni D, Luraghi C, Perilli E, Borelli M, Pacei M, et al. treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness. FASEBJ. 2009;23(4):1196-204.

(44.) Libby P, Crea F. Clinical implications of inflammation for cardiovascular primary prevention. Eur Heart J. 2010;31(7):777-83.

(45.) Ryan ME, Camu 0, Tenzler R. The impact of periodontitis on metabolic control and risk for diabetic complications. Grand Rounds in Oral-Systemic Medicine. 2006;1 (2):24-34A.

(46.) Bartold PM, Marshall RI, Haynes DR. Periodontitis and rheumatoid arthritis: A review. J Periodontal. 2005;76:2066-2074.

(47.) Ushida Y, Koshy G, Kawashima Y, Kiji M, Umeda M, Nitta H, et al. Changes in serum interleukin-6, C-reactive protein and thrombomodulin levels under periodontal ultrasonic debridement. J Clin Periodontal. 2008;35(11):969-75.

(48.) Ide M, McPartlin D, Coward PY, Crook M, Lumb P, Wilson RF. Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses. J Clin Periodontal. 2003;30(4):334-40.

(49.) Offenbacher S, Beck JD, Moss K, Mendoza L, Paquette DW, Barrow DA, et al. Results from the Periodontitis and Vascular Events (PAVE) study: A pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontal. 2009;80(2):190-201.

(50.) de Oliveira C, Watt R, Hamer M. Toothbrushing, inflammation and risk of cardiovascular disease: Results from Scottish Health Survey. BMJ. 2010;340(c2451).

(51.) Arinzon Z, Peisakh A, Schrire S, Berner Y. C-reactive protein (CRP): An important diagnostic and prognostic tool in nursing home-associated pneumonia. Arch Gerontol Geriatr. 2011 NovDec; 53(3):364-69. doi: 10.1016/j.archger.2011.01.006.Epub2011 Mar 24.

Salme E Lavigne *, PhD, RDH; Malcolm B Doupe ([section]), PhD; Anthony M Iacopino ([dagger]), DMD, PhD; Salaheddin M Mahmud ([section][DELTA]), MD, PhD

* School of Dental Hygiene, College of Dentistry, University of Manitoba, Canada

([section]) Max Rady College of Medicine, University of Manitoba, Canada

([dagger]) College of Dentistry, University of Manitoba, Canada

([DELTA]) College of Pharmacy, University of Manitoba, Canada

Correspondence: Salme E Lavigne, PhD, RDH; salme.lavigne@umanitoba.ca Manuscript submitted 31 July 2017; revised 17 January 2018; accepted 1 February 2018
Table 1. Comparisons of mean age, gender, cognitive
performance scores, and comorbidities across study
groups at baseline

                                          Both groups     Usual care
                                            (n = 54)       (n = 25)

Mean age (SD)                             85.S3 (8.54)   85.24 (9.44)

Sex
  Male (%)                                  36 (67)        15 (60)
  Female (%)                                18 (33)        10 (40)

CPS scores (%)
  0 to 1 (Intact-borderline)               12 (22.2)       7 (28.0)
  2 to 3 (Mild to moderate impairment)     22 (40.7)      10 (40.0)
  4 to 6 (Severe to very                   20 (37.1)       8 (32.0)
  severe impairment)

Comorbidity
  A) Overall (%)
    0 disease                                0 (0)          0 (0)
    1 to 2 diseases                         10 (19)         5 (20)
    >3 diseases                             44 (81)        20 (80)
  B) Specific diseases (%)
    Dementia/Alzheimer                      39 (72)        17 (68)
    Stroke                                  14 (26)         9 (36)
    CVD                                     39 (72)        20 (80)
    Arthritis                               10 (19)         1 (4)
    Diabetes                                11 (20)         2 (8)
    Cancer                                  10 (19)         9 (36)
    Other                                   30 (56)        13 (52)

                                           Powerbrush    P value
                                            (n = 29)

Mean age (SD)                             85.76 (7.68)    0.825

Sex                                                       0.335
  Male (%)                                  21 (72)        --
  Female (%)                                 8 (28)        --

CPS scores (%)                                            0.599
  0 to 1 (Intact-borderline)                5 (17.2)       --
  2 to 3 (Mild to moderate impairment)     12 (41.4)       --
  4 to 6 (Severe to very                   12 (41.4)       --
  severe impairment)

Comorbidity
  A) Overall (%)                                          0.795
    0 disease                                0 (0)         --
    1 to 2 diseases                          5 (17)        --
    >3 diseases                             24 (83)        --
  B) Specific diseases (%)
    Dementia/Alzheimer                      22 (76)       0.529
    Stroke                                   5 (17)       0.121
    CVD                                     19 (66)       0.244
    Arthritis                                9 (31)       0.010
    Diabetes                                 9 (31)       0.037
    Cancer                                   1 (3)        0.002
    Other                                   17 (59)       0.625

Table 2. Baseline comparisons in hsCRP
measures across study groups

Outcome               Both Groups Median       Usual Care Median
                     (Interquartile range)   (Interquartile range)

High sensitivity       4.0 (2.7 to 10.0)       5.2 (2.7 to 10.4)
C-reactive protein
(hsCRP) *

Outcome                Powerbrush Median     P value
                     (Interquartile range)

High sensitivity       3.5 (2.08 to 8.5)      0.407
C-reactive protein
(hsCRP) *

* Scores below 1.0 mg/L indicate no risk for cardiovascular events.
Anything above a 3.0 Is associated with a higher risk of
cardiovascular disease.

Table 3. Changes (week 6 minus baseline) in high-sensitivity
C-reactive protein (hsCRP) scores, overall and for both
study groups

6-Week CRP-Baseline CRP   Median (Interquartile range)

Both groups (n = 51)          0.200 (-2.10 to 4.28)

Usual care (n = 23)          -0.100 (-5.00 to 5.60)

Powerbrush (n = 28)           0.375 (-1.78 to 2.47)

Table 4. Assessment of changes in hsCRP over time,
within people and across study groups

                         Mean rank             P value

Within-person change       32.48               0.719 *
  Both groups (n = 51)     18 33               0.564 *
  Powerbrush (n = 28)      14.32               0.839 *
  Usual care (n = 23)
Between-group
differences
  Powerbrush (n = 28)      27.88     Pvalue              [X.sup.2(1)]
  Usual care (n = 23)      26.02     0.662 *                0.191
COPYRIGHT 2018 The Canadian Dental Hygienists Association
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:ORIGINAL RESEARCH
Author:Lavigne, Salme E.; Doupe, Malcolm B.; Iacopino, Anthony M.; Mahmud, Salaheddin M.
Publication:Canadian Journal of Dental Hygiene
Article Type:Report
Geographic Code:1CMAN
Date:Feb 1, 2018
Words:6107
Previous Article:Implementation of an enriched ultrasonic curriculum into a Canadian dental hygiene program.
Next Article:Granuloma gravidarum associated with pregnancy: A case report.
Topics:

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |